Aligos Therapeutics, Inc. (ALGS)
9.12
-0.53
(-5.49%)
USD |
NASDAQ |
Dec 30, 16:00
9.10
-0.02
(-0.22%)
Pre-Market: 20:00
Aligos Therapeutics Price: 9.12 for Dec. 30, 2025
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| CEL-SCI Corp. | 5.23 |
| AIM ImmunoTech, Inc. | 1.26 |
| IGC Pharma, Inc. | 0.2825 |
| NovaBay Pharmaceuticals, Inc. | 6.20 |
| Protalix Biotherapeutics, Inc. | 1.74 |
Price Related Metrics
| PS Ratio | 30.77 |
| PEG Ratio | -0.0096 |
| Price to Book Value | 0.7813 |
| Earnings Yield | -216.7% |
| Market Cap | 56.12M |
| PEGY Ratio | -0.0096 |